Technology explainer
How Can a Blood Test Estimate Biological Age?
Biological-age tests combine many biomarkers with statistical or machine-learning models. Their scores can reveal population-level patterns, but training targets, disease effects, laboratory variation, and limited clinical validation make them very different from a clock that measures how long someone will live.
A biological-age test does not find a hidden birthday inside the body. It measures a set of biomarkers, compares them with patterns learned from other people, and returns a score that summarizes how old those measurements appear.
What can be measured?
Researchers have built aging clocks from DNA methylation, gene activity, metabolites, medical images, physical performance, and proteins circulating in blood. A proteomic clock may combine dozens or hundreds of proteins whose concentrations tend to change with age. Some reflect inflammation, metabolism, tissue repair, immune activity, or organ function.
How does a clock learn age?
A model needs a training target. The simplest target is chronological age: the algorithm learns which biomarker combinations best distinguish younger from older participants. Other clocks are trained to predict mortality, frailty, or the future risk of age-related disease. Two tests can therefore examine the same blood sample and produce different answers because they were built to answer different questions.
Machine-learning methods assign weights to biomarkers and combine them into a prediction. Researchers then validate the model in people who were not used for training. A useful clock should remain reasonably accurate across laboratories, populations, and timepoints, rather than memorizing the original dataset.
What does a younger score mean?
At a population level, an age estimate below chronological age may correlate with lower risk or healthier function. For one person, however, the score is not a direct measurement of how quickly every organ is aging. Illness, medication, exercise, infection, weight change, and laboratory handling can alter biomarkers without changing the fundamental rate of aging.
This is especially important in treatment studies. If a drug reduces inflammation caused by a disease, an aging clock that uses inflammatory proteins may report a younger age. That could be beneficial, but it does not prove the drug slowed aging throughout the body.
Why compare several clocks?
Agreement across independently developed clocks reduces the chance that a result depends on one model's quirks. It is strongest when the clocks use different biomarker sets and training targets. Yet agreement still cannot remove a shared confounder, such as a disease that affects many of the same proteins.
What would make the evidence stronger?
- Define the aging outcome before the trial begins.
- Use a randomized control group and enough participants to detect realistic effects.
- Repeat measurements to separate persistent change from short-term fluctuation.
- Connect clock changes to physical function, disease incidence, and long-term health.
- Replicate the result independently in diverse populations.
Aging clocks can be valuable research instruments and may help screen interventions more quickly. Their most responsible use is as one layer of evidence, alongside clinical outcomes and biological mechanisms, rather than as a personal countdown or proof that a treatment extends life.
First appeared in
Six Aging Clocks Agreed on One Drug, but They Cannot Prove It Slowed Aging
